Authors: Wang, Xianxiang
Zhang, Yiquan
Xiao, Jin
Zhang, Ke
Li, Qingxin
Chen, Hongwei
Liu, Fei
Title: 18 beta-glycyrrhetinic acid ameliorates the cognitive functions and decreases the recurrence rate of pituitary adenomas patients
Language (ISO): en
Abstract: Pituitary adenomas, the most common tumors of all intracranial neoplasms, may cause either symptoms of mass effect or symptoms of hormone abnormal production. Besides physical damages, patients with pituitary adenomas always suffer from cognitive impairments, mainly in memory and executive functions. 18 beta-glycyrrhetinic acid (GA) has been found to exhibit anti-tumor effects in rat pituitary adenoma-derived cells. The aim of this paper was to investigate the effect of GA in postoperative clinical application. In this study, we recruited 647 patients with pituitary adenoma and 135 patients who dropped out were excluded from analysis. Thus, altogether 512 patients with pituitary adenoma completed the study, of whom 268 were treated with GA, and 244 were treated with placebo. Cognitive assessments, eyesight, tumor size, and hormone secretion levels were examined before and after surgery in both groups. All patients underwent surgeries by single-nostril transsphenoidal approach for their firsttime medical treatment. Hormone secretion levels were measured by blood samples and Magnetic resonance imaging (MRI) was used for examining the status of tumor excision. Compared with placebo group, the scores in orientation, language (expression), memory (recall), practice, abstract thinking, and MiniMental State Examination (MMSE) were significantly improved (p < 0.05) in GA treated group after one month of surgery. After six months, there was still a significant increase in abstract thinking scores. Moreover, GA did not impact the overall survival percentage of patients enrolled during our five-year follow-up, but significantly reduced the recurrence rate than that of the placebo group. GA significantly improved the cognitive functions at the early stage after surgery and had a long-termed efficacy on abstract thinking. Notably, GA inhibited the five-year recurrence rate of the recruited pituitary adenomas patients.
Subject Headings: Pituitary adenoma
Cognitive function
18 beta-glycyrrhetinic acid (GA)
Recurrence rate
URI: http://hdl.handle.net/2003/37660
http://dx.doi.org/10.17877/DE290R-19655
Issue Date: 2018-07-27
Appears in Collections:Original Articles

Files in This Item:
File Description SizeFormat 
Wang_27072018_proof.pdfDNB230.04 kBAdobe PDFView/Open


This item is protected by original copyright



All resources in the repository are protected by copyright.